Avalo Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$18.48

-0.81 (-4.20%)

As of Jun 30, 10:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 18 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +78.1% upside

Low Target $27.78

Average Target $32.91

High Target $47.11

Current Price $18.48

Current
$18.48

Target
$32.91

$27.78 $32.91 avg $47.11

Scenario Analysis

Bear Case

$27.78

50.3%

Low target

Base Case

$32.91

+78.1%

Avg target

Bull Case

$47.11

+154.9%

High target

Risk/Reward

3.1x

Highly favorable

Price in Context

52-Week High

$24.27

-23.9% from high

52-Week Low

$4.50

+310.7% from low

Target vs 52W High

$32.91

+35.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%